María Antonia Pérez-Moreno

4PUBLICATIONS
6CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2024
Antiemetic prophylaxis regimens in haematologic malignancies patients undergoing a hematopoietic stem cell transplantation. Which is the best standard of care? A systematic review.

Nerea Báez-Gutiérrez, Paloma Suárez-Casillas, Maria Antonia Pérez-Moreno

|Oct 14, 2023
Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review.

María Antonia Pérez-Moreno, Pablo Ciudad-Gutiérrez, Didiana Jaramillo-Ruiz

|Sep 28, 2021
Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.

Rocío Jiménez Galán, Elena Prado-Mel, María Antonia Pérez-Moreno

|Jun 04, 2019
The role of clinical pharmacists in the optimisation of medication prescription and reconciliation on admission in an emergency department.

José Javier Arenas-Villafranca, Juan Manuel Rodríguez-Camacho, María Antonia Pérez-Moreno

Pageof 1

Frequent Collaborators

1 joint publications

Elena Prado-Mel

1 joint publications

Estefanía Caballano-Infantes

1 joint publications

Nerea Báez-Gutiérrez

1 joint publications

Paloma Suárez-Casillas